Extracellular Zn2+ via activation of ZnR/GPR39 in the prostate cancer cell line PC-3 enhances expression of S100A4 [84], a protein that is thought to enhance metastatic prostate cell proliferation and angiogenesis [177]. The gene discussed is GPR39; the disease is prostate carcinoma.